The Growing Semaglutide Market is Projected to driven by increasing prevalence of diabetes
Semaglutide is an injectable glucagon-like peptide-1 (GLP-1) receptor agonist used to manage Type 2 diabetes and obesity. It works by stimulating the release of insulin …